Product Description:

• Tecentriq is used in the treatment of Hepatocellular Carcinoma; Small Cell Lung Cancer; Alveolar Soft Part Sarcoma; Non-Small Cell Lung Cancer; and Melanoma and belongs to the drug class anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors).
• Tecentriq 1200 mg/20 mL solution for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).

How to use:

• Tecentriq 1200mg Injection is given as an injection into veins under the supervision of a doctor.
• Your doctor will decide what dose is necessary and how often you need to take it.
• This will depend on what you are being treated for and may change from time to time.

Caution & Warnings:

• Black, tarry stools
• Bladder pain
• Bloating or swelling of the face, arms, hands, lower legs, or feet
• Bloody or cloudy urine
• Blurred vision
• Body aches or pain
• Chest tightness, chills
• Constipation
• Cough
• Diarrhea
• Difficult, burning, or painful urination
• Difficulty in peathing
• Dizziness
• Ear congestion,fever
• Frequent urge to urinate
• General feeling of tiredness and weakness,headache
• Hoarseness
• Loss of appetite
• Loss of voice,pale skin

Ingredients:

• Atezolizumab1200 mg/20 mL.